182 related articles for article (PubMed ID: 37470145)
1. Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis.
Ge J; Zhang Q; Ma H; Wang D; Zhao Y; Zhu T; Wang W; Zhou C; Wei A; Lian H; Qin M; Yang J; Li Z; Wang T; Zhang R
Haematologica; 2024 Feb; 109(2):458-465. PubMed ID: 37470145
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
[TBL] [Abstract][Full Text] [Related]
3. [Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis].
Wei A; Ma HH; Zhang LP; Lian HY; Du JY; Wang D; Cui L; Ou WX; Zhao YZ; Zhao XX; Zhang L; Li ZG; Wang TY; Zhang R
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2167-2172. PubMed ID: 35872580
[No Abstract] [Full Text] [Related]
4. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation.
Böhm S; Wustrau K; Pachlopnik Schmid J; Prader S; Ahlmann M; Yacobovich J; Beier R; Speckmann C; Behnisch W; Ifversen M; Jordan M; Marsh R; Naumann-Bartsch N; Mauz-Körholz C; Hönig M; Schulz A; Malinowska I; Hines M; Nichols KE; Gil-Herrera J; Talano JA; Crooks B; Formankova R; Jorch N; Bakhtiar S; Kühnle I; Streiter M; Nathrath M; Russo A; Dürken M; Lang P; Lindemans C; Henter JI; Lehmberg K; Ehl S
Blood; 2024 Mar; 143(10):872-881. PubMed ID: 37992218
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults.
He L; Wang Y; Suolitiken D; Zhang R; Liu M; Hua Z; Yao S; Zou H; Wang Z
Hematol Oncol; 2022 Aug; 40(3):390-399. PubMed ID: 35526261
[TBL] [Abstract][Full Text] [Related]
6. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
7. Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children.
Zhao C; Zhang Q; Zhang R; Lian H; Ma H; Zhao X; Li Z
Ann Hematol; 2024 Jan; 103(1):17-28. PubMed ID: 37851074
[TBL] [Abstract][Full Text] [Related]
8. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580
[TBL] [Abstract][Full Text] [Related]
9. A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis.
Zhang Q; Zhao YZ; Ma HH; Wang D; Cui L; Li WJ; Wei A; Wang CJ; Wang TY; Li ZG; Zhang R
Blood; 2022 Jun; 139(24):3493-3504. PubMed ID: 35344583
[TBL] [Abstract][Full Text] [Related]
10. Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.
Trantham T; Auten J; Muluneh B; Van Deventer H
J Oncol Pharm Pract; 2020 Jun; 26(4):1005-1008. PubMed ID: 31575356
[TBL] [Abstract][Full Text] [Related]
11. Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT.
Meng G; Wang J; Wang X; Wang Y; Wang Z
Ann Hematol; 2020 Feb; 99(2):343-349. PubMed ID: 31879790
[TBL] [Abstract][Full Text] [Related]
12. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children.
Wei A; Ma H; Li Z; Zhang L; Zhang Q; Wang D; Lian H; Zhang R; Wang T
Int J Hematol; 2020 Oct; 112(4):568-576. PubMed ID: 32666469
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
Yan WL; Yang SL; Zhao FY; Xu XJ
J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
[TBL] [Abstract][Full Text] [Related]
14. Development and application of an LC-MS/MS method for pharmacokinetic study of ruxolitinib in children with hemophagocytic lymphohistiocytosis.
Li Z; Sun N; Zhang Q; Ma HH; Wang D; Zhao YZ; Yang CQ; Zhang R; Zhao LB
Anal Methods; 2022 Jun; 14(23):2293-2303. PubMed ID: 35635540
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
[TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib for hematopoietic cell transplantation-associated hemophagocytic lymphohistiocytosis.
Ono R; Ashiarai M; Hirabayashi S; Mizuki K; Hosoya Y; Yoshihara H; Ohtake J; Mori S; Manabe A; Hasegawa D
Int J Hematol; 2021 Feb; 113(2):297-301. PubMed ID: 32979171
[TBL] [Abstract][Full Text] [Related]
17. Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis.
Song Y; Li X; He X; Zhou F; Du F; Wang Z; Chen S; Wu D
Front Immunol; 2023; 14():1211655. PubMed ID: 37457729
[TBL] [Abstract][Full Text] [Related]
18. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.
Bergsten E; Horne A; Aricó M; Astigarraga I; Egeler RM; Filipovich AH; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Montgomery S; Nanduri V; Rosso D; Henter JI
Blood; 2017 Dec; 130(25):2728-2738. PubMed ID: 28935695
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of ruxolitinib in children with hemophagocytic lymphohistiocytosis: focus on the drug-drug interactions.
Li Z; Zhang Q; He H; Sun N; Zhang R; Yang CQ; Zhao LB
Cancer Chemother Pharmacol; 2023 Feb; 91(2):121-132. PubMed ID: 36510033
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of haploidentical hematopoietic stem cell transplantation on 15 cases of adult-onset primary hemophagocytic lymphohistiocytosis].
Wang YN; Wang JS; Wei N; Wu L; Jin ZL; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):511-516. PubMed ID: 32654467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
